Amplification and overexpression of prosaposin in prostate cancer
- 3 August 2005
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 44 (4), 351-364
- https://doi.org/10.1002/gcc.20249
Abstract
We identified prosaposin (PSAP) as a secreted protein expressed in androgen‐independent (AI) prostate cancer cells by cloning/sequencing, after probing a PC‐3 cDNA library expressed in the λTriplEx phagemid expression vector with a polyclonal rabbit antibody generated against pooled human seminal plasma. PSAP is a neurotrophic molecule; its deficiency or inactivation has proved to be lethal in man and mice, and in mice, it leads to abnormal development and atrophy of the prostate gland, despite normal testosterone levels. We used Southern hybridization, quantitative real‐time polymerase chain reaction, and/or single nucleotide polymorphism (SNP) array analysis, and we now report the genomic amplification of PSAP in the metastatic AI prostate cancer cell lines, PC‐3, DU‐145, MDA‐PCa 2b, M‐12, and NCI‐H660. In addition, by using SNP arrays and a set of 25 punch biopsy samples of human prostate cancer xenografts (LAPC3, LuCaP 23.1, 35, 49, 58, 73, 77, 81, 86.2, 92.1, 93, 96, 105, and 115), lymph nodes, and visceral‐organ metastases, we detected amplification of the PSAP locus (10q22.1) in LuCaP 58 and 96 xenografts and two lymph node metastases. In addition, AI metastatic prostate cancer cell lines C4‐2B and IA8‐ARCaP over‐expressed PSAP mRNA without evidence of genomic amplification. Taken together with prior data that demonstrated the growth‐, migration‐, and invasion‐promoting activities, the activation of multiple signal transduction pathways, and the antiapoptotic effect of PSAP (or one of its active domains, saposin C) in prostate cancer cells, our current observation of PSAP amplification or overexpression in prostate cancer suggests, for the first time, a role for this molecule in the process of carcinogenesis or cancer progression in the prostate.Keywords
This publication has 51 references indexed in Scilit:
- Molecular Mechanisms of Prostate CancerEuropean Urology, 2004
- Establishment and characterization of a primary androgen‐responsive African‐American prostate cancer cell line, E006AAThe Prostate, 2004
- LuCaP 35: A new model of prostate cancer progression to androgen independenceThe Prostate, 2003
- Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signalingOncogene, 2001
- Future prospects in prostate cancerThe Prostate, 1999
- Genetic Alterations in Hormone-Refractory Recurrent Prostate CarcinomasThe American Journal of Pathology, 1998
- Prosaposin Receptor: Evidence for a G-Protein-Associated ReceptorBiochemical and Biophysical Research Communications, 1997
- Expression of the Three Alternative Forms of the Sphingolipid Activator Protein Precursor in Baby Hamster Kidney Cells and Functional Assays in a Cell Culture SystemPublished by Elsevier BV ,1996
- Expression and tissue distribution of rat sulfated glycoprotein-1 (prosaposin).Journal of Histochemistry & Cytochemistry, 1996
- Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expressionInternational Journal of Cancer, 1994